Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Biotronik, Inc. |
---|---|
Information provided by: | Biotronik, Inc. |
ClinicalTrials.gov Identifier: | NCT00395642 |
This feasibility study will investigate the clinical benefit of the combined use of BIOTRONIK Home Monitoring (HM) and weight and blood pressure external telemonitoring (ETM) in the follow-up treatment of patients implanted with a CRT-D. The feasibility study is designed to plan and define endpoints for a larger randomized study. The study will assess the HM-parameter trends correlation with daily weight and blood pressure changes. The patient compliance rate of the two different telemonitoring systems (HM & ETM) will also be evaluated.
Condition | Intervention | Phase |
---|---|---|
Congestive Heart Failure Cardiac Resynchronization Therapy |
Device: Kronos LV-T, Lumax HF-T |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
Official Title: | TRIAGE-CRT Telemonitoring in Patients With Congestive Heart Failure and Indication of ICD-Cardiac Resynchronization Therapy |
Estimated Enrollment: | 200 |
Study Start Date: | November 2006 |
Estimated Study Completion Date: | September 2008 |
Estimated Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
A
Device based Home Monitoring and weight and BP remote monitoring
|
Device: Kronos LV-T, Lumax HF-T
Implanted CRT-device sends out device diagnostics (e.g. heart rate, device and lead integrity, patient activity) via CardioMessenger on daily basis. In addition, daily weight and BP readings are taken; remote data are analyzed by investigational sites via the internet on a weekly basis.
|
This single-arm, multi-center feasibility study will explore the clinical benefit of the combined use of BIOTRONIK Home Monitoring and weight and blood pressure telemonitoring in the follow-up management of heart failure patients implanted with a Cardiac Resynchronization Therapy Implantable Cardioverter Defibrillator (CRT-D). The BIOTRONIK Home Monitoring system will automatically and remotely collect device based information on a daily basis, and an external telemonitoring system will be used to determine the 'weight' and 'blood pressure' remotely at the patient's home on a daily basis. This study will evaluate retrospectively, if Home Monitoring parameters correlate with weight and blood pressure changes. The patient compliance rate of the two telemonitoring systems will also be assessed. Target enrollment is up to 100 patients at 15 U.S. sites. Patients will be enrolled within a period of 12 to 15 months. Based on the follow-up period of 6 months per patient, the study duration is 18 to 21 months from the date of first patient enrollment. All patients will give written informed consent prior to enrollment and will be implanted with the legally marketed BIOTRONIK Kronos LV-T, or an appropriate BIOTRONIK CRT-D, as well as legally marketed pacing and defibrillation leads. In addition, all patients will be receiving a legally marketed external telemonitoring system to determine weight and blood pressure at home.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, South Carolina | |
Spartanburg Regional | |
Spartanburg, South Carolina, United States, 29303 |
Principal Investigator: | Joseph Akar, MD | Loyola University |
Responsible Party: | Biotronik, Inc ( Horst Flathmann, PhD / Clinical Studies Engineer ) |
Study ID Numbers: | 20061653 |
Study First Received: | November 1, 2006 |
Last Updated: | May 14, 2008 |
ClinicalTrials.gov Identifier: | NCT00395642 History of Changes |
Health Authority: | United States: Institutional Review Board |
Congestive Heart Failure Cardiac Resynchronization Therapy Home Monitoring Telemonitoring Remote Monitoring |
Heart Failure Heart Diseases |
Heart Failure Heart Diseases Cardiovascular Diseases |